← SynDRA
TERAMEPROCOL
SynDRA canonical compound SYN0003568 — structure-anchored drug synonym record
| Clinical phase | Phase 1/Phase 2 |
|---|
| Primary target(s) | BIRC5 | CDK1 |
|---|
| Mechanism of action | lipoxygenase inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- lipoxygenase inhibitor
- SP1 MODULATOR
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
Cross-references
Synonyms
- EM-1421
- EM1421
- Terameprocol (INN/USAN)
- Meso-Tetra-O-methylnordihydroguaiaretic acid
- Meso-Tetramethoxy-4,4'-(2,3-dimethyltetramethylene)dipyrocatechol
- Meso-1,4-Bis-(3,4-dimethoxyphenyl)-2,3-dimethylbutane
- 4-[(2S,3R)-4-(3,4-dimethoxyphenyl)-2,3-dimethylbutyl]-1,2-dimethoxybenzene
- EM 1421
- Tmndga
- meso-Tetra-O-methylnordihydroguaiaretic acid
- tetra-O-methyl NDGA
- Tetra-O-methylnordihydroguaiaretic acid
- terameprocolum
- 4,4'-(2,3-Dimethyl-1,4-butanediyl)bis-1,2-dimethoxybenzene
- NSC136955
- FW 358.2
- RefChem:891363
- Terameprocol [USAN:INN]
- UNII-53YET703F2
- meso-tetra-O-methyl nordihydroguaiaretic acid
- TERAMEPROCOL [INN]
- TERAMEPROCOL [USAN]
- MLS006010717
- SCHEMBL194588
- TERAMEPROCOL [WHO-DD]
- orb1306216
- meso-1,4-Bis-(3,4-dimethoxyphenyl)-2,3-dimethylbutane
- SCHEMBL30094578
- Terameprocol, >=98% (HPLC)
- CHEBI:177824
- ORQFDHFZSMXRLM-IYBDPMFKSA-N
- (2R,3S)-2,3-dimethyl-1,4-bis(3,4-bimethoxylphenyl)-butane
- Tetramethylnordihydroguaiaretic acid
- tetramethyl Nordihydroguaiaretic Acid
- EBC-474045
- NCGC00346832-01
- BP-42848
- HY-10447
- MS-25644
Look up TERAMEPROCOL in the interactive SynDRA portal →